Tumor markers: from laboratory to clinical utility.
Schrohl AS, Holten-Andersen M, Sweep F, Schmitt M, Harbeck N, Foekens J, Brünner N; European Organisation for Research and Treatment of Cancer (EORTC) Receptor and Biomarker Group.
Schrohl AS, et al.
Mol Cell Proteomics. 2003 Jun;2(6):378-87. doi: 10.1074/mcp.R300006-MCP200. Epub 2003 Jun 17.
Mol Cell Proteomics. 2003.
PMID: 12813140
Free article.
Review.
No abstract available.